Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Pharma — Retail - Pharmacy. Per the activity note to the FY2021 annual report, the company carries out retail and wholesale trade in pharmaceutical products and personal hygiene items.
Group parent — controls 1 company · ownership
| Line item | 2018 | 2019 | 2020 | 2021 | CAGR |
|---|---|---|---|---|---|
| Net Cash from Operating Activities | 501 | 1,074 | 1,795 | 81 | -45.6% |
| Net Cash used in Investing Activities | 91 | 12 | 50 | 380 | +61.2% |
| Free Cash Flow (OCF − Capex proxy) | 410 | 1,063 | 1,746 | 299 | nmf |
| Net Cash from Financing Activities | 91 | 925 | 712 | 451 | nmf |
| Net Change in Cash (before FX) | 502 | 137 | 1,034 | 750 | nmf |
| Effect of FX on Cash | 46 | 8 | 135 | 17 | nmf |
| Net Change in Cash (incl. FX) | 548 | 145 | 1,169 | 767 | nmf |
| Cash at Beginning of Year | 22 | 570 | 715 | 1,883 | +342.7% |
| Cash at End of Year | 570 | 715 | 1,883 | 1,116 | +25.1% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →